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of the risk factors will lead to gene-informed personalized preven-
tion (2). It is thus important to identify genes that confer
susceptibility to coronary artery disease (CAD). Furthermore,
stratification of subjects based on conventional risk factors for
CAD and prospective cohort studies are also important to accom-
plish personalized medicine. In our study (1), low-risk individuals
were defined as those who did not have any of the three major risk
factors (hypertension, diabetes mellitus, and hypercholesterol-
emia). Given that the study is a cross-sectional association study,
the classification of subjects as low-risk or high-risk was not based
on the prevalence of myocardial infarction (MI) after follow-up of
10 years. Although a survivor bias could not be excluded com-
pletely, it was likely to be small in our study because of a relatively
low prevalence of fatal MI (approximately 20%) in Japan. The
variant alleles of four single nucleotide polymorphisms (SNPs)
significantly associated with CAD are thus markers of predispo-
sition to CAD.
Although the 786T3C SNP of the endothelial nitric oxide
(eNOS) gene was related to CAD in the total population and in
high-risk men, the p values were 0.0484 (additive model) and
0.0369 (dominant model), respectively (1). In an initial screening
of the 112 polymorphisms for association with MI in 909 subjects
in our previous study (3), the 786T3C SNP of eNOS gene was
related to MI in men and women. In a large-scale association
study, however, this SNP was not significantly associated with MI
in men or women (3). The characteristics of ideal association study
include a large sample size, small p values, an association that
makes biological sense, and alleles that affect the gene product in
a physiologically meaningful way (4). Two studies with a p value of
0.01 or a single study with a p value of 0.001 other than the
first positive study is strongly predictive of future replication (5).
Given that we adopted a criterion of a p value of 0.005 as
statistical significance for association (1), the relation of the
786T3C SNP of eNOS gene with CAD was considered not to
be significant. Although this SNP was shown to be associated with
coronary artery spasm (6), the relation of this SNP with CAD
remains to be elucidated.
In a stepwise forward selection procedure, four SNPs signifi-
cantly associated with CAD were all statistically independent of
age, smoking, or hyperuricemia as well as hypertension, diabetes
mellitus, and hypercholesterolemia. As Drs. Rossi and Maiolino
point out, the presence of hypertension, diabetes mellitus, and
hypercholesterolemia may blunt nitric oxide availability. However,
the 1019C3T SNP of the connexin-37 gene in high-risk men and
the 3932C3T SNP of the apolipoprotein E gene in high-risk
women were statistically independent of these risk factors.
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Therapeutic Transcutaneous
Ultrasound: Long Overdue Therapy
The recent report by Miyamoto et al. (1) presents the results of an
experimental study evaluating the coronary vessel dilatory effect of
transcutaneous low-frequency ultrasound. The investigators used a
quite sophisticated animal model and demonstrated by various
means that transcutaneous ultrasound induces vasodilation in
canine coronary arteries. The magnitude of the effect was similar to
that found with intracoronary nitrates. The researchers very
correctly concluded that this phenomenon may be used as a
therapeutic tool to reduce myocardial ischemia in patients with
acute coronary syndromes.
Interestingly, in 1980 we first performed experimental and later
clinical studies using approximately similar doses of transcutaneous
ultrasound. The ultrasound frequency in our study was 790 to 910
kHz, with the ultrasound of 0.2 to 0.45 W/cm2. The first case of
transcutaneous ultrasound therapy in a patient was performed in
early 1981 and later published in a USSR patent (2).
We completely agree with the editorial comments of Drs.
McPherson and Holland (3) who postulated that this effect of
ultrasound is strictly mechanical (acoustic radiation, streaming,
and cavitation). Recently, we demonstrated that similar effects can
be achieved with other forms of electromagnetic radiation (4,5).
In conclusion, we want to congratulate the investigators on a
very interesting study, and we believe that further preclinical and
clinical data may prove the safety and efficacy of this long overdue
form of therapy, namely transcutaneous therapeutic ultrasound for
treatment of ischemia.
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REPLY
We believe the potential benefits of ultrasound include enhance-
ment of thrombolysis, vasodilation, and increased tissue perfusion.
Transcutaneous ultrasound in animals facilitates thrombolysis (1).
A pilot trial of transcutaneous low-frequency ultrasound, in com-
bination with tissue-type plasminogen activator (t-PA), has shown
feasibility and safety to treat patients with acute myocardial
infarction (2).
The study by Miyamoto et al. (3) found that the coronary
arteries as well as the coronary veins dilate in response to
transthoracic low-frequency ultrasound. Transcutaneous low-
frequency ultrasound augments ST-segment elevation resolution
in dogs with coronary occlusion treated with t-PA (4). Suchkova et
al. (5) found that ultrasound improves tissue perfusion in ischemic
limbs, which is associated with capillary dilation. Pretreatment
with an inhibitor of nitric oxide synthase blocked ultrasound
enhancement of tissue perfusion and capillary dilation. These
findings indicate that the effects of ultrasound are mediated
through the nitric oxide. Based on this work, it is likely that
ultrasound promotes mechanical shear on the endothelial cells and,
thus, release of nitric oxide. This thesis is in agreement with that
of Drs. Kipshidze.
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Transient Ischemic Dilation
Abidov et al. (1) note an increased cardiac event rate in follow-up
of patients found to have transient ischemic dilation (TID) as the
sole abnormality on stress myocardial perfusion single-photon
emission computed tomography (SPECT). However, the finding
of severe coronary disease in only a minority (5 of 20) of such
patients is in contrast to previous reports (2,3), which conclude
TID to be highly specific for severe coronary disease, and it
suggests that there are alternate or additional mechanisms to that
of balanced diffuse endocardial ischemia due to epicardial coronary
stenosis.
Earlier experimental studies have demonstrated a decreased
endocardial-to-epicardial flow ratio in response to adenosine (4,5),
tachycardia (4), and hypotension (6), particularly in the presence of
left ventricular hypertrophy (LVH) and elevated left ventricular
end-diastolic pressure (LVEDP) (4–6), as well as coronary steno-
sis. In addition, redistribution of transmural perfusion would be
expected to produce a more pronounced increase in the TID ratio
in the presence of LVH, due to a greater subendocardial-to-
subepicardial distance. One recent clinical report (7) associates
TID, in the absence of focal perfusion defect, with hypertensive
LVH.
The possibility that TID may represent a nonspecific marker of
stress-induced subendocardial underperfusion by one or more of a
number of possible mechanisms and may thus serve as a surrogate
of various risk factors for a future cardiac event should be
considered. As this phenomenon may not truly be “ischemic” nor
represent genuine left ventricular dilation, the term “transient
ischemic dilation” may be a misnomer.
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